Colon cancer | Page 12 of 16

Colorectal Cancer :: Early colon cancer diagnosis with colonoscopies made possible by Medicare

Early colon cancer or colorectal cancer diagnosis was made possible by changes in Medicare reimbursement policy few years back. The study was published by Yale School of Medicine researchers in the December issue of Journal of the American Medical Association (JAMA). The study was funded by a Beeson Career Development Award to Gross, and by the Claude D. Pepper Older Americans Independence Center at Yale.

Gene :: Cancer genes to better and earlier detection of lung, breast, prostate and colon cancer

A research team at UT Southwestern Medical Center has for the first time identified several genes whose expression is lost in four of the most common solid human cancers — lung, breast, prostate and colon cancer.

Colorectal Cancer :: More patients diagnosed at earlier stage of colon cancer

Since Medicare raised the amount it will reimburse for colon cancer screening in 1998, there has been an increase in use of colonoscopies by Medicare beneficiaries, and a rise in the proportion of patients being diagnosed with colon cancer at an early stage, according to a study in the Dec. 20 issue of JAMA.

Colorectal Cancer :: Estrogen study provides new impetus for development of colon cancer drugs

The female hormone estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests.

Echinacea :: Cold-Season Cure or Risk – antimicrobial effects of echinacea

When sneezing and a prickly throat signal an oncoming cold, many people reach for what they believe will be a safe preventative ? a tea or capsule containing echinacea. In the first study to examine the effects of a botanical supplement on bacteria in the gastrointestinal tract, research at the University of Arkansas suggests people may be risking some unwelcome side effects with this common herbal remedy.

Colorectal Cancer :: Stool DNA testing for colon cancer

Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer?s location in the colon.

Colorectal Cancer :: Xeloda meets primary endpoint in multinational Phase III advanced colorectal cancer study

Roche announced today that a large, international Phase III study (NO16967) of 627 previously treated patients with advanced colorectal cancer met its primary endpoint of progression-free survival.

Colon Cancer :: Vigorous daily exercise can cut the risk of colon cancer

One hour a day of vigorous physical activity or two hours of moderate activity reduces the risk of colon cancer by 22 per cent, European researchers say. And for those who are not overweight, the risk of developing the disease is reduced even further.

DNA :: Inheritance outside DNA

At the 2006 American Society for Cell Biology conference, scientists will report an increase in tumor frequency in mice with mutations in a cancer-associated gene, called Apc. This finding may contribute to scientific understanding about the epigenetic changes involved in colon cancer.

Consumer-driven health plans slow to catch on, 2nd annual survey finds

Americans have not yet warmed to consumer-driven health plans, a relatively new kind of coverage that offers reduced premiums but carries higher annual deductibles. Enrollment in consumer-driven plans remains low, and satisfaction continues to lag when compared with more comprehensive health insurance, according to a survey released today by the Employee Benefit Research Institute and the Commonwealth Fund, nonpartisan organizations.